Join
Live feed
·
PRReleasevia Quantisnow
Isleworth Healthcare Acquisition Corporation logo

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress

ByQuantisnow·Wall Street's wire, on your screen.
ISLE· Isleworth Healthcare Acquisition Corporation
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ISLE (Isleworth Healthcare Acquisition Corporation) and more on Quantisnow.